Week Ending 04-20-18: The femtech movement and what is means for women’s health, Frost and Sullivan forecast $50B potential in femtech market by 2025, Boston Scientific buys nVision Medical
Elvie co-founder Tania Boler helped raise 10 million euros for the company’s technology, proving that femtech is taking off. Healthcare is seeing a major disruption across the industry and Elvie is no exception. As digital transformation revolutionizes the wearable tech market, Elvie can be found at the intersection of lifestyle tech and healthtech — connecting women and their bodies through technology. Read more.
Boston Scientific’s purchase of nVision Medical, a corporation dedicated to women’s health, continues to support the booming femtech trend. As the developer of the “first and only” FDA approved medical device to collect cells from fallopian tubes (expected to help with the early detection of ovarian cancer), Boston Scientific anticipates nVision’s “near-term market opportunity to be $500 million with the potential to grow to $2 billion.” Read more.
With the rise of the femtech movement, Reenita Das highlights the impending need for “gender-specific healthcare solutions.” As healthcare continues on its path towards increased personalization, companies are responding with gender-specificity in everything from prosthetics, wearable tech, drug development and more. Read more.
Frost and Sullivan research has revealed that “50% of global healthcare customers are women.” With an estimated $50B in femtech potential, it comes as no surprise that healthcare is finally trending toward women’s health. Companies are eagerly addressing the many unmet needs of women; Frost and Sullivan attribute digital transformation as one of the main drivers. Read more.
Wired Health 2018 shone its spotlight not only on the femtech revolution, but on the women behind it. Featuring sessions from Dr. Claire Novorol, chief medical officer of the AI-driven doctor app Ada, as well as medical device company Elvie co-founder, Tania Boler, Wired tapped into the disruption transforming the healthcare industry. Read more.